232 related articles for article (PubMed ID: 15946250)
1. Maintenance of long-term tumour-specific T-cell memory by residual dormant tumour cells.
Mahnke YD; Schwendemann J; Beckhove P; Schirrmacher V
Immunology; 2005 Jul; 115(3):325-36. PubMed ID: 15946250
[TBL] [Abstract][Full Text] [Related]
2. A novel tumour model system for the study of long-term protective immunity and immune T cell memory.
Mahnke YD; Schirrmacher V
Cell Immunol; 2003 Feb; 221(2):89-99. PubMed ID: 12747949
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of a potent tumor vaccine-induced secondary anti-tumor T cell response.
Mahnke YD; Schirrmacher V
Int J Oncol; 2004 Jun; 24(6):1427-34. PubMed ID: 15138584
[TBL] [Abstract][Full Text] [Related]
4. EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells.
Müller M; Gounari F; Prifti S; Hacker HJ; Schirrmacher V; Khazaie K
Cancer Res; 1998 Dec; 58(23):5439-46. PubMed ID: 9850077
[TBL] [Abstract][Full Text] [Related]
5. IL-15-dependent upregulation of GITR on CD8 memory phenotype T cells in the bone marrow relative to spleen and lymph node suggests the bone marrow as a site of superior bioavailability of IL-15.
Snell LM; Lin GH; Watts TH
J Immunol; 2012 Jun; 188(12):5915-23. PubMed ID: 22581858
[TBL] [Abstract][Full Text] [Related]
6. Vitamin C treatment of mouse bone marrow-derived dendritic cells enhanced CD8(+) memory T cell production capacity of these cells in vivo.
Jeong YJ; Kim JH; Hong JM; Kang JS; Kim HR; Lee WJ; Hwang YI
Immunobiology; 2014 Jul; 219(7):554-64. PubMed ID: 24698552
[TBL] [Abstract][Full Text] [Related]
7. CD8 cell division maintaining cytotoxic memory occurs predominantly in the bone marrow.
Parretta E; Cassese G; Barba P; Santoni A; Guardiola J; Di Rosa F
J Immunol; 2005 Jun; 174(12):7654-64. PubMed ID: 15944266
[TBL] [Abstract][Full Text] [Related]
8. GITR-dependent regulation of 4-1BB expression: implications for T cell memory and anti-4-1BB-induced pathology.
Lin GH; Snell LM; Wortzman ME; Clouthier DL; Watts TH
J Immunol; 2013 May; 190(9):4627-39. PubMed ID: 23536631
[TBL] [Abstract][Full Text] [Related]
9. IL-15 inhibits IL-7Rα expression by memory-phenotype CD8⁺ T cells in the bone marrow.
Quinci AC; Vitale S; Parretta E; Soriani A; Iannitto ML; Cippitelli M; Fionda C; Bulfone-Paus S; Santoni A; Di Rosa F
Eur J Immunol; 2012 May; 42(5):1129-39. PubMed ID: 22539288
[TBL] [Abstract][Full Text] [Related]
10. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
Bristol JA; Schlom J; Abrams SI
Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
[TBL] [Abstract][Full Text] [Related]
11. Naive, effector, and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.
Cerwenka A; Morgan TM; Dutton RW
J Immunol; 1999 Nov; 163(10):5535-43. PubMed ID: 10553081
[TBL] [Abstract][Full Text] [Related]
12. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
Homma S; Komita H; Sagawa Y; Ohno T; Toda G
Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514
[TBL] [Abstract][Full Text] [Related]
13. Tumor-immune memory T cells from the bone marrow exert GvL without GvH reactivity in advanced metastasized cancer.
Schirrmacher V; Beckhove P; Choi C; Griesbach A; Mahnke Y
Int J Oncol; 2005 Oct; 27(4):1141-9. PubMed ID: 16142333
[TBL] [Abstract][Full Text] [Related]
14. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization.
Bour H; Horvath C; Lurquin C; Cerottini JC; MacDonald HR
J Immunol; 1998 Jun; 160(11):5522-9. PubMed ID: 9605156
[TBL] [Abstract][Full Text] [Related]
15. CD8+ memory T cells (CD44high, Ly-6C+) are more sensitive than naive cells to (CD44low, Ly-6C-) to TCR/CD8 signaling in response to antigen.
Curtsinger JM; Lins DC; Mescher MF
J Immunol; 1998 Apr; 160(7):3236-43. PubMed ID: 9531279
[TBL] [Abstract][Full Text] [Related]
16. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response.
Kedl RM; Mescher MF
J Immunol; 1998 Jul; 161(2):674-83. PubMed ID: 9670942
[TBL] [Abstract][Full Text] [Related]
17. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of in vivo proliferation and death of memory and naive CD8 T cells: parameter estimation based on 5-bromo-2'-deoxyuridine incorporation in spleen, lymph nodes, and bone marrow.
Parretta E; Cassese G; Santoni A; Guardiola J; Vecchio A; Di Rosa F
J Immunol; 2008 Jun; 180(11):7230-9. PubMed ID: 18490722
[TBL] [Abstract][Full Text] [Related]
19. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting.
Pahl-Seibert MF; Juelch M; Podlech J; Thomas D; Deegen P; Reddehase MJ; Holtappels R
J Virol; 2005 May; 79(9):5400-13. PubMed ID: 15827154
[TBL] [Abstract][Full Text] [Related]
20. Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.
Jeyanathan M; Mu J; McCormick S; Damjanovic D; Small CL; Shaler CR; Kugathasan K; Xing Z
Am J Respir Crit Care Med; 2010 Apr; 181(8):862-72. PubMed ID: 20019338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
